DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 78 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2014. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $2,177,000 | +694.5% | 101,247 | +257.0% | 0.01% | +800.0% |
Q2 2017 | $274,000 | +66.1% | 28,359 | +2.5% | 0.00% | 0.0% |
Q1 2017 | $165,000 | +68.4% | 27,667 | +11.2% | 0.00% | – |
Q4 2016 | $98,000 | -62.5% | 24,881 | 0.0% | 0.00% | -100.0% |
Q3 2016 | $261,000 | -28.1% | 24,881 | 0.0% | 0.00% | -50.0% |
Q2 2016 | $363,000 | -22.4% | 24,881 | +5.5% | 0.00% | 0.0% |
Q1 2016 | $468,000 | -18.5% | 23,594 | -0.7% | 0.00% | 0.0% |
Q4 2015 | $574,000 | +6.3% | 23,749 | +8.0% | 0.00% | 0.0% |
Q3 2015 | $540,000 | +20.0% | 21,988 | +14.6% | 0.00% | 0.0% |
Q2 2015 | $450,000 | +1.6% | 19,193 | -2.9% | 0.00% | 0.0% |
Q1 2015 | $443,000 | +31.8% | 19,760 | -0.9% | 0.00% | +100.0% |
Q4 2014 | $336,000 | – | 19,939 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |